GlassScriptPhysician profile
Bose Yalamanchi
NPI 1194700476
$4,986.37
in general payments reported to CMS, 2019-2025
18 companies · $1,884 in 2025
The $1,884 reported for 2025 was more than what 83% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,349 · 2020: $287 · 2021: $278 · 2022: $448 · 2023: $299 · 2024: $440 · 2025: $1,884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,677 · Debt Forgiveness: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,676.61 |
| Debt Forgiveness | $947.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,169.74 | 2021-2025 | Grafix Pl, Stravix Pl, Oasis Micro |
| Allergan, INC. | $1,142.64 | 2019-2021 | |
| Johnson & Johnson Health Care Systems INC. | $947.61 | 2025 | |
| Integra Lifesciences Corporation | $529.34 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $256.32 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Motiva USA, LLC | $192.22 | 2025 | |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Avita Medical Americas, LLC | $148.33 | 2024 | |
| Southern Edge Orthopaedics, INC. | $121.47 | 2025 | |
| Sientra, INC. | $105.18 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $87.80 | 2023 | |
| Misonix INC | $26.10 | 2020 | |
| Endo Pharmaceuticals INC. | $23.84 | 2020 | |
| Acera Surgical, INC. | $23.38 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $17.52 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $16.31 | 2020 | |
| Tei Biosciences INC | $15.11 | 2019 | |
| Apyx Medical Corporation | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bose Yalamanchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.